Orgenesis Valuation
| ORGS Stock | USD 0.51 0.01 2.00% |
Orgenesis is undervalued. Orgenesis holds a recent Real Value of $1.87 per share. The prevailing price of the company is $0.51. Our model determines the value of Orgenesis from analyzing the company fundamentals such as Shares Owned By Insiders of 20.35 %, return on equity of -3.39, and Current Valuation of 38.84 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors support acquiring undervalued entities and selling overvalued entities since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Orgenesis' valuation include:
Price Book 1.3886 | Enterprise Value 38.8 M | Enterprise Value Ebitda (2.33) | Price Sales 0.6066 | Enterprise Value Revenue 1.402 |
Undervalued
Today
Please note that Orgenesis' price fluctuation is abnormally volatile at this time. Calculation of the real value of Orgenesis is based on 3 months time horizon. Increasing Orgenesis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Orgenesis is useful when determining the fair value of the Orgenesis stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Orgenesis. Since Orgenesis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Orgenesis Stock. However, Orgenesis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.51 | Real 1.87 | Target 6.0 | Hype 0.44 |
The real value of Orgenesis Stock, also known as its intrinsic value, is the underlying worth of Orgenesis Company, which is reflected in its stock price. It is based on Orgenesis' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Orgenesis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Orgenesis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Orgenesis helps investors to forecast how Orgenesis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Orgenesis more accurately as focusing exclusively on Orgenesis' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Orgenesis' intrinsic value based on its ongoing forecasts of Orgenesis' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Orgenesis' closest peers. When choosing an evaluation method for Orgenesis, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Orgenesis Investments |
|
Orgenesis Valuation Trend
Knowing Orgenesis' actual value is paramount for traders to make sound investment determinations. Orgenesis' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Orgenesis' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Orgenesis' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Orgenesis Market Cap
Orgenesis is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 2.58 Billion. Orgenesis maintains roughly 17.2 Million in market capitalization contributing less than 1% to equities under Health Care industry.Orgenesis Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Orgenesis's current stock value. Our valuation model uses many indicators to compare Orgenesis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orgenesis competition to find correlations between indicators driving Orgenesis's intrinsic value. More Info.Orgenesis is considered to be number one stock in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 0.18 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Orgenesis is roughly 5.42 . Price To Book Ratio is likely to drop to -0.73 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Orgenesis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Orgenesis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orgenesis' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Orgenesis' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Orgenesis and how it compares across the competition.
About Orgenesis Valuation
The stock valuation mechanism determines the current worth of Orgenesis on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Orgenesis. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Orgenesis based exclusively on its fundamental and basic technical indicators. By analyzing Orgenesis's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Orgenesis's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orgenesis. We calculate exposure to Orgenesis's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Orgenesis's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 631 K | 599.5 K | |
| Pretax Profit Margin | (121.59) | (115.51) | |
| Operating Profit Margin | (101.20) | (96.14) | |
| Net Loss | (104.45) | (99.23) | |
| Gross Profit Margin | (10.80) | (10.26) |
8 Steps to conduct Orgenesis' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Orgenesis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Orgenesis' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Orgenesis' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Orgenesis' revenue streams: Identify Orgenesis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Orgenesis' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Orgenesis' growth potential: Evaluate Orgenesis' management, business model, and growth potential.
- Determine Orgenesis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Orgenesis' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Orgenesis Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Orgenesis does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 29 M |
Orgenesis Current Valuation Indicators
Valuation refers to the process of determining the present value of Orgenesis and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Orgenesis we look at many different elements of the entity such as Orgenesis's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Orgenesis' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Orgenesis' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Orgenesis, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Orgenesis' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Orgenesis' worth.When determining whether Orgenesis is a strong investment it is important to analyze Orgenesis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Orgenesis' future performance. For an informed investment choice regarding Orgenesis Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orgenesis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Orgenesis Stock analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Orgenesis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orgenesis. If investors know Orgenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orgenesis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Revenue Per Share 0.018 | Quarterly Revenue Growth (0.99) | Return On Assets (0.62) | Return On Equity (3.39) |
The market value of Orgenesis is measured differently than its book value, which is the value of Orgenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Orgenesis' value that differs from its market value or its book value, called intrinsic value, which is Orgenesis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orgenesis' market value can be influenced by many factors that don't directly affect Orgenesis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orgenesis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Orgenesis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orgenesis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.